Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark A. Prygocki Sr currently holds 20,000 shares of Clarus Therapeutics Holdings, Inc. (CRXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark A. Prygocki Sr has been a net seller of CRXT stock. They have purchased $59.3K and sold $5.7M worth of shares.
Mark A. Prygocki Sr's most recent insider trade was on Jun 6, 2024, when they sold 20,000 shares at $0.00 per share.
Mark A. Prygocki Sr serves as Executive at Clarus Therapeutics Holdings, Inc. (CRXT). They have executed 51 insider transactions totaling $5.7M over their tenure at the company.
Mark A. Prygocki Sr holds the position of Executive at Clarus Therapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mark A. Prygocki Sr has shown a selling trading pattern, with $59.3K in total purchases and $5.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark A. Prygocki Sr was on Dec 11, 2012, when they sold $13.3M worth of MRX shares. This transaction involved 301,613 shares at $44.00 per share.
Mark A. Prygocki Sr currently owns 20,000 shares of Clarus Therapeutics Holdings, Inc. (CRXT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark A. Prygocki Sr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark A. Prygocki Sr has 51 Form 4 filings on record as an insider at Clarus Therapeutics Holdings, Inc..
Set alerts for Mark A. Prygocki Sr and 40,000+ other insiders.